Advertisement

Topics

FDA fast-tracks Tonix's Alzheimer's disease drug

06:32 EDT 17 Jul 2018 | SmartBrief

Tonix Pharmaceuticals' TNX-102 SL was designated fast-track status by the FDA.  -More

Original Article: FDA fast-tracks Tonix's Alzheimer's disease drug

NEXT ARTICLE

More From BioPortfolio on "FDA fast-tracks Tonix's Alzheimer's disease drug"

Advertisement
Quick Search
Advertisement
Advertisement